A novel frequent BRCA1 allele in Chinese patients with breast cancer

Abstract

The whole length of exon 11 of BRCA1 was sequenced (total 3427 bp) in 59 patients and 10 healthy female blood donors. To allow a rapid determination of the different BRCA1 alleles, a sequence-specific primer PCR method (PCR-SSP) was established and was applied to 57 additional female donors. Finally, the full-length coding region of BRCA1 was analyzed through reversed-transcriptase PCR (RT-PCR) and cDNA sequencing (total 5554 bp) in one donor with wild-type allele and 2 patients with one or two matated alleles. By genomic DNA sequencing, 5 homozygous polymorphisms were observed in 18 patients: 2201C>T, 2430T>C, 2731C>T, 3232A>G and 3667A>G All of them were previously observed in Caucasians, Malay and Chinese, but for the first time the mutations were found in one allele (GenBank AY304547). Twenty-six patients and 4 donors were heterozygous at these 5 nucleotide positions. The remaining 15 patients and 6 donors showed a sequence identical with the standard BRCA1 gene. Combined the PCR-SSP results and in a summary, 6 of 67 (9.0 %) healthy individuals were homozygous for the mutated allele, whereas 18 of 59 (30.5 %) breast cancer patients were homozygous. A Chi-square test showed a significant correlation between homozygous mutated BRCA1 allele and breast cancer. The cDNA sequencing showed that 2 additional mutations, 4427T>C in exon 13 and 4956A>G in exon 16, were found. A new BRCA1 allele, which is BRCA1-2201T/2430C/2731T/3232G/3667G/4427C/4956G (GenBank AY751490), was found in Chinese. And the homozygote of this mutated allele may implicate a disease-association in Chinese.

Keywords

BRCA1 / sequencing / single nucleotide polymorphism / PCR-SSP / Chinese

References

[1] FodorF. H., WestonA., BleiweissI. J., et al.. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet, 1998, 63: 45-51

[2] FordD., EastonD. F., StrattonM., et al.. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 1998, 62: 676-689

[3] KeY., WangX., FengM., et al.. Analysis of mutation sites of BRCA1 gene in Chinese patients with breast cancer. Chin J med Genet (Chinese), 2002, 19: 383-385

[4] KhooU. S., NganH. Y., CheungA. N., et al.. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat, 2000, 16: 88-89

[5] KhooU. S., ChanK. Y., CheungA. N., et al.. Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat, 2002, 19: 307-308

[6] SngJ. H., ChangJ., FerozeF., et al.. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer, 2000, 82: 538-542

[7] TangN. L., PangC. P., YeoW., et al.. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst, 1999, 91: 882-885

[8] ZhenL., WuZ., FanP., et al.. Mutation analysis in breast cancer susceptibility gene-1 in 23 Chinese familial breast cancer patients. Acta Universitatis Medicinalis Nanjing (Natural Science) (Chinese), 2002, 22: 191-193

[9] ZhiX., SzaboC., ChopinS., et al.. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat, 2002, 20: 474-479

[10] SteinmannD., BremerM., RadesD., et al.. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br J Cancer, 2001, 85: 850-858

[11] ShaoC. P., MaasJ. H., SuY. Q., et al.. Molecular background of Rh D-positive, D-negative, D^el and weak D phenotypes in Chinese population. Vox Sang, 2002, 83(2): 156-161

[12] DunningA. M., ChianoM., SmithN. R., et al.. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet, 1997, 6: 285-289

[13] HanW., KangD., ParkI. A., et al.. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res, 2004, 10: 124-130

[14] OsorioA., de la HoyaM., Rodriguez-LopezR., et al.. Over-representation of two specific haplotypes among chromosomes harboring BRCA1 mutations. Eur J Hum Genet, 2003, 11: 489-492